Tag
This nationwide study examines visual and anatomical responses to anti-VEGF retreatment in diabetic macular edema patients who returned with stabilized vision after being lost to follow-up, highlighting suboptimal gains and implications for
This study reveals distinct structure-function correlations in early atrophic AMD, showing lesion size correlates with localized sensitivity loss, while lesion proximity to the fovea predicts central vision and reading outcomes, supporting
Interim real-world data over nearly 4 years confirms the long-term safety and sustained visual benefits of voretigene neparvovec-rzyl in treating inherited retinal dystrophies, with manageable procedure-related adverse events including chor
An exploratory trial of UGX-201, a novel optogenetic therapy, demonstrated safety and meaningful visual improvements in patients with advanced nonsyndromic retinitis pigmentosa, including restoration of light perception in those previously
A large multicenter study found that MIPS measure 191 captures high cataract surgery success rates but excludes many patients and may require case-mix adjustment to support fair surgeon comparisons.
THEIA trial evaluated intravenous alteplase against oral aspirin in acute CRAO within 4.5 hours; no significant visual improvement difference was found, emphasizing the need for further research and meta-analyses to clarify thrombolysis ben
A recent randomized, double-blind trial demonstrates that oral lamivudine significantly improves visual acuity in patients with center-involved diabetic macular edema, offering a cost-effective and safer alternative to conventional anti-VEG
